SCHEMBL17799672

SCHEMBL17799672

O=C(N[C@H]1CC[C@H]1c1ccc(F)cc1F)c1c(F)cccc1Cl

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 9/20 0.56
▸ LMNA P02545 1/20 0.56
▸ PKM P14618 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ HCRTR1 O43613 3/20 0.53
▸ PPIA P62937 1/20 0.45
▸ TAS1R3 Q7RTX0 2/20 0.44
▸ TAS1R1 Q7RTX1 2/20 0.44
▸ TAS1R2 Q8TE23 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ MAPT P10636 1/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ TLR7 Q9NYK1 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ JAK2 O60674 1/20 0.41
▸ JAK1 P23458 1/20 0.41
▸ TYK2 P29597 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17799700 0.91 HCRTR1 (0.49) GAALMNAPKMKMT2AHCRTR1
SCHEMBL17799678 0.86 GAA (0.53) GAALMNAPKMKMT2AHCRTR1
SCHEMBL17799733 0.86 HCRTR1 (0.50) GAALMNAPKMKMT2AHCRTR1
SCHEMBL16372345 0.86 GAA (0.53) GAALMNAPKMKMT2AHCRTR1
SCHEMBL17799695 0.86 HCRTR1 (0.46) GAALMNAPKMKMT2AHCRTR1
SCHEMBL17799746 0.82 MC1R (0.45) GAALMNAPKMKMT2AHCRTR1
SCHEMBL17799692 0.81 HCRTR1 (0.49) GAALMNAHCRTR1PPIATAS1R3
SCHEMBL17799682 0.81 GAA (0.55) GAALMNAPKMKMT2AHCRTR1
SCHEMBL16372251 0.81 GAA (0.55) GAALMNAPKMKMT2AHCRTR1
SCHEMBL17799725 0.81 GAA (0.46) GAAHCRTR1TAS1R3TAS1R1TAS1R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE50724-E1 4-membered ring carboxamides used as nematicides SYNGENTA CROP PROTECTION AG (CH) 2026-01-06 — — US disclosed
US-9867371-B2 4-membered ring carboxamides used as nematicides SYNGENTA PARTICIPATIONS AG (CH) 2018-01-16 — — US disclosed
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2016-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES TUBA3C, DDT, CYCS GAA 2228/4885LMNA 3548/4885PKM 3884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback